Personalized cancer treatment
delivered with AI
AI Startup of the Year
DoMore Diagnostics has been awarded the prestigious title of "AI Startup of the Year" by the Norwegian Artificial Intelligence Research Consortium (NORA) for its pioneering use of artificial intelligence to personalize cancer treatment.
Read more here.
Latest News
Solid scientific foundation
DoMore Diagnostics was established to meet the need for novel methods in precision medicine to personalize treatment for each cancer patient and is based on prominent international research from leading universities (University in Oslo, Oxford University and University College of London). The research project was selected as a Lighthouse project by the Norwegian Research Council to develop new diagnostic methods for cancer based on artificial intelligence. The project was led by the late Prof. Håvard Danielsen with an aim to utilize new technologies to reduce over- and undertreatment of cancer by providing a new system for cancer prognosis. The lack of objective and precise methods for cancer prognosis is a limiting step to enable precision medicine to cancer patients worldwide.
Artificial intelligence in cancer diagnostics
Artificial intelligence is set for a breakthrough in medicine, and several megatrends support new solutions in cancer diagnostics. Digital pathology and new AI algorithms will play a significant role in the future of medicine and hold multiple commercial opportunities. Watch Professor Marco Novelli at University College of London talk about the future of artificial intelligence in pathology.
